Broadfin Capital as of March 31, 2018
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 50 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| La Jolla Pharmaceuticl Com Par | 7.7 | $49M | 1.7M | 29.78 | |
| Mirati Therapeutics | 6.9 | $44M | 1.4M | 30.70 | |
| Heron Therapeutics (HRTX) | 6.8 | $44M | 1.6M | 27.60 | |
| Horizon Pharma | 6.3 | $41M | 2.9M | 14.20 | |
| Corium Intl | 5.6 | $36M | 3.1M | 11.47 | |
| Adamas Pharmaceuticals | 4.2 | $27M | 1.1M | 23.90 | |
| Retrophin | 4.1 | $26M | 1.2M | 22.36 | |
| Strongbridge Bioph shs usd | 3.9 | $25M | 2.8M | 8.85 | |
| Recro Pharma | 3.8 | $25M | 2.2M | 11.01 | |
| Zogenix | 3.4 | $22M | 537k | 40.05 | |
| Gw Pharmaceuticals Plc ads | 3.1 | $20M | 175k | 112.67 | |
| Flamel Technologies Sa | 3.0 | $19M | 2.6M | 7.29 | |
| Aratana Therapeutics | 3.0 | $19M | 4.3M | 4.41 | |
| Integra LifeSciences Holdings (IART) | 2.6 | $17M | 298k | 55.34 | |
| Catalyst Pharmaceutical Partners (CPRX) | 2.5 | $16M | 6.8M | 2.39 | |
| AngioDynamics (ANGO) | 2.5 | $16M | 912k | 17.25 | |
| Iovance Biotherapeutics (IOVA) | 2.4 | $15M | 913k | 16.90 | |
| NuVasive | 2.1 | $14M | 258k | 52.21 | |
| AMAG Pharmaceuticals | 1.9 | $12M | 599k | 20.15 | |
| Kala Pharmaceuticals | 1.7 | $11M | 681k | 15.83 | |
| Antares Pharma | 1.6 | $10M | 4.7M | 2.20 | |
| BioDelivery Sciences International | 1.5 | $9.6M | 4.3M | 2.25 | |
| Glaukos (GKOS) | 1.4 | $9.1M | 294k | 30.83 | |
| Anaptysbio Inc Common (ANAB) | 1.3 | $8.2M | 79k | 104.08 | |
| CIGNA Corporation | 1.1 | $7.1M | 43k | 167.75 | |
| Merck & Co (MRK) | 1.1 | $7.1M | 131k | 54.47 | |
| Noveliontherapeuti.. | 1.1 | $6.8M | 1.9M | 3.50 | |
| Sol Gel Technologies | 1.0 | $6.7M | 648k | 10.30 | |
| Vericel (VCEL) | 1.0 | $6.6M | 659k | 9.95 | |
| Amarin Corporation | 1.0 | $6.3M | 2.1M | 3.01 | |
| Esperion Therapeutics (ESPR) | 1.0 | $6.3M | 87k | 72.33 | |
| Paratek Pharmaceuticals | 1.0 | $6.2M | 478k | 13.00 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.9 | $6.0M | 15M | 0.40 | |
| Teligent | 0.9 | $5.7M | 1.7M | 3.36 | |
| Pacira Pharmaceuticals (PCRX) | 0.8 | $5.2M | 167k | 31.15 | |
| Oxford Immunotec Global | 0.7 | $4.7M | 374k | 12.45 | |
| Natus Medical | 0.6 | $3.8M | 114k | 33.65 | |
| Progenics Pharmaceuticals | 0.6 | $3.7M | 500k | 7.46 | |
| Varian Medical Systems | 0.6 | $3.7M | 30k | 122.67 | |
| Invitae (NVTAQ) | 0.6 | $3.5M | 750k | 4.69 | |
| Veracyte (VCYT) | 0.5 | $3.3M | 601k | 5.56 | |
| Adma Biologics (ADMA) | 0.5 | $3.3M | 721k | 4.60 | |
| Tetraphase Pharmaceuticals | 0.5 | $3.2M | 1.0M | 3.07 | |
| Mediwound Ltd cmn | 0.4 | $2.6M | 500k | 5.20 | |
| Scynexis | 0.4 | $2.5M | 1.9M | 1.34 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $1.5M | 376k | 4.00 | |
| Invuity | 0.2 | $1.2M | 299k | 3.85 | |
| Contrafect | 0.1 | $635k | 390k | 1.63 | |
| Ovascience | 0.1 | $442k | 545k | 0.81 | |
| Strata Skin Sciences | 0.0 | $238k | 203k | 1.17 |
